Latin America Oncology Device Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Oncology devices are wide range of medical devices used in treatment of cancer. Oncology devices are in-vitro diagnosis and combination device products used in screening, diagnosing, treating, and monitoring premalignant and malignant conditions in patients. Moreover, the increasing number of people suffering from cancer is driving demand for oncology devices. This in turn, is expected to drive the market growth during the forecast period. For instance, in 2019, according to the article published in the Journal of Clinical Oncology in September 2019, in Brazil, the calculated cost per patient suffering from cervical cancer was US$ 7,942 for radiotherapy alone and US$ 8,774 for chemo- radiotherapy.

Market Dynamics

Key companies operating in the market are focusing on product launches and obtaining approvals from regulatory agencies which is expected to facilitate growth of the Latin America oncology devices market during the forecast period. For instance, in December 2017, Varian Medical Systems of Palo Alto, a radiation oncology treatment and software company, received ANVISA approval in Brazil for its Halcyon system. Halcyon simplifies and enhances every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT), and is well suited to treat majority of cancer patients, offer advanced treatments for prostate, breast, head & neck, and many other forms of cancer.

Moreover, government regulating bodies are focused on enhancing digital healthcare and approving new products for treatment of cancer. For instance, in March 2020, MedX Health Corp., a medical device and software company, received regulatory approval from ANVISA to market and sell its SIAscopy on DermSecure skin assessment platform in Brazil. SIAscopy is an imaging technology and a solution for early detection of skin cancer.

Key players in the market are focused on adopting innovative technologies for the development of devices. For instance, in January 2018, ACE Medical launched the AutoMed 3300 Ambulatory Infusion System which is a convenient pump. The pump is fitted with a self-checking system, which will electronically monitor and alert the patient or caregiver of delivery issues via an audible alarm.

Key features of the study:

• This report provides in-depth analysis of the Latin America oncology devices market and provides market size (US$ Mn), market volume (units), and compound annual growth rate (CAGR) (%) for the forecast period (2020 – 2027)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, country outlook, and competitive strategies adopted by the leading players.
• It profiles leading players in the Latin America oncology devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• Key companies covered as a part of this study include Medtronic plc, ACE Medical, VOGT Medical, Becton, Dickinson and Company, Smiths Medical, Inc, Samtronic Industria e Comercio LTDA, Codan Argus AG, B. Braun Melsungen AG, Medical Components, Inc., Fresenius SE & Co. KGaA, Baxter International Inc., EuroLife Healthcare Pvt. Ltd, and Micrel Medical Devices
• The Latin America oncology devices market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the Latin America oncology devices market

Detailed Segmentation:

Latin America Oncology Device Market, By Chemotherapy Administration :

• Gravity Chemotherapy Administration
• Syringe Chemotherapy Administration
• Pump Chemotherapy Administration
• Others

Latin America Oncology Device Market, By Accessories and Consumables :

• Infusion Sets
• Venous Access
• Ports
• Needle
• Catheter
• CVC
• PIC
• Needleless Connectors
• Syringe Filters
• Software

Latin America Oncology Device Market, By Age Group :

• Pediatric
• Infant ( from birth to 1 year)
• Children ( 4 to 10 years )
• Teenager/ Adolescent ( 11 to 19 years )
• Adults

Latin America Oncology Device Market, By End User :

• Private Hospitals/ Clinics
• General Hospitals with Oncology Centers
• Specialized Hospitals
• Specialized Clinics
• Public Hospitals / Clinics
• General Hospitals with Oncology centers
• Hospitals
• Clinics
• Others
• Homecare Settings
• Research Institutes

Latin America Oncology Device Market, By Country :

• Brazil
• Mexico
• Chile
• Company Profiles
• Medtronic plc *
• Company Overview
• Product Portfolio
• Financial Performance
• Key Highlights
• Market Strategies
• ACE Medical
• VOGT Medical
• Becton, Dickinson and Company
• Smiths Medical, Inc.
• Samtronic Industria e Comercio LTDA
• Codan Argus AG
• B. Braun Melsungen AG
• Medical Components, Inc.
• Fresenius SE & Co. KGaA
• Baxter International Inc.
• EuroLife Healthcare Pvt. Ltd.
• Micrel Medical Devices

“*” marked represents similar segmentation in other categories in the respective section.